This webinar is provided by National Jewish Health
This educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.
COPD remains a leading cause of death in the United States and each exacerbation increases the chance of mortality, yet COPD exacerbations are not generally considered as severe as a heart attack. Literature reveals that many patients with COPD are not effectively diagnosed until they are hospitalized. Early recognition, appropriate diagnosis, and effective treatment of COPD is urgent in light of the mortality, morbidity and economic consequences of the disease. This activity includes case-based scenarios that highlight key issues related to early diagnosis, exacerbation prevention, treatment of COPD, and patient-centered strategies for communication and personalized treatment selection.
Date and Time
This webinar will be held on four separate days
CME/CE credit provided